Addressing Sterile Manufacturing Challenges

Published on: 

Keynote SeriesPharmaceutical Technology and BioPharm International are sponsoring a Keynote Series discussion on addressing sterile manufacturing challenges on the INTERPHEX 2016 Exhibit Hall Innovation Stage. Admission is free to any attendee with an exhibit hall pass.

Wednesday April 27, 3:30–4:30 pm
Panel Discussion: Addressing Sterile Manufacturing Challenges
Sterile injectables have been in extremely short supply, and industry efforts have been focusing on root causes involving infrastructure, quality, and efficiency. Experts involved in this work discuss recent initiatives, and offer insights into what must be done to prevent injectables shortages in the future.

Maik Jornitz, President, G-CON Manufacturing Inc
Bill Hartzel, Director – Strategic Execution, Catalent Pharma Solutions
Chris Procyshyn, CEO, Vanrx Pharmasystems
Anil-Kumar Busimi, Director, Strategic Marketing and Innovation, Schott
Vinod Vilivalam, Director of Strategic Marketing and Technical Development, Americas, Daikyo Seiko